ORTEXORTEX News
Tracking CAE? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CA
Trader NoteCAE

CAE Holds Steady as Shorts Build Into May Earnings

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 30 Apr 2026, 00:07

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CAE enters the final stretch before its May 29 quarterly report with a quiet price chart masking a sharp acceleration in short interest — while the borrow market itself tells a very different story about conviction.

Short interest has climbed nearly 70% over the past month to 1.48% of the free float, with the bulk of that move happening in the week of April 21. That is a significant rate of change for a stock not typically associated with heavy short selling. Yet the borrow market signals this is not a high-conviction short: cost to borrow has collapsed to just 0.44%, down more than 50% over the past month, and availability remains extremely loose — utilization is running at 1.8%, well below the 52-week peak of 4.13%. Cheap, readily available borrows suggest the shorts building here are not facing any squeeze pressure, but they are also not the kind of committed, hard-to-borrow crowd that typically precedes a material downside thesis.

Price action reinforces that image of a market sitting on its hands. CAE ended the week effectively flat at C$34.94, barely moving while close peers absorbed real damage — LOAR and VSEC each lost more than 9% over the same five sessions, and AIR fell more than 6%. That the stock absorbed the aerospace sector sell-off without flinching is notable, though it starts from a weaker base after a 2.6% decline over the prior month.

The Street is broadly constructive but trimming its numbers. The analyst consensus mean target sits at C$47, implying roughly 35% upside from current levels — a gap large enough to attract value-oriented buyers. Recent activity is split: Canaccord has issued positive forecasts, National Bank maintained an outperform even as it cut earnings estimates, and TD lowered its target to C$49. Jefferies shaved its USD target to $27 in mid-April, though the CAD-denominated consensus remains well above the current price. The note from National Bank cutting near-term estimates is worth watching, given the EPS momentum factor ranks in the 84th percentile over 30 days — revisions have been running upward even as some houses dial back individual line items. The P/E of 26.2x has compressed by roughly three turns over the past month, bringing valuation somewhat closer to the historical range, while EV/EBITDA trades at around 11.9x.

Among institutional holders, one notable development from the last reporting period is 1832 Asset Management building a position of roughly 22 million shares — a new stake representing nearly 7% of outstanding shares — while Browning West trimmed by about 1.1 million shares. La Caisse de dépôt et placement du Québec remains the anchor holder at 9.6%. Insider data is stale (last reported trades date to December 2025) and is not reflected here.

The two most recent earnings releases both produced negative one-day reactions of 3% to 4%, with five-day moves of a similar magnitude. The May 29 print is the next concrete date around which positioning will crystallise — whether the ongoing short interest build reflects pre-earnings hedging or something more structural will become clearer as that date approaches and borrow conditions either tighten or remain as relaxed as they are today.

Stocks in this article

See the live data behind this article on ORTEX.

Open CAE on ORTEX →

How this article was generated

Generated
30 Apr 2026, 00:08
Data as of
30 Apr 2026, 00:07
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signals

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.